Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tauriga Sciences Inc (TAUG)

Tauriga Sciences Inc (TAUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 35
  • Shares Outstanding, K 348,895
  • Annual Sales, $ 290 K
  • Annual Income, $ -3,630 K
  • 60-Month Beta 1.54
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TAUG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $-0.01 on 02/16/22
  • Latest Earnings Date 04/05/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 unch
on 01/13/23
0.0001 unch
on 01/13/23
N/A (unch)
since 12/09/22
3-Month
0.0001 unch
on 01/13/23
0.0065 -98.46%
on 10/14/22
-0.0057 (-98.28%)
since 10/13/22
52-Week
0.0001 unch
on 01/13/23
0.0350 -99.71%
on 01/14/22
-0.0355 (-99.72%)
since 01/13/22

Most Recent Stories

More News
Tauriga Sciences Inc. Chief Executive Officer Completes 1,500,000 Share Insider Purchase

New York, NY, May 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order

Company Sets New Quarterly Record for Number of Individual E-Commerce Order Transactions New York, NY, March 25, 2022 (GLOBE NEWSWIRE) --...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Invited to Participate in the Upcoming Kroger “Merchandising Planogram and Sales Planning” Event

New York, NY, March 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Receives its 9,000th E-Commerce Order

New York, NY, Jan. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Generates Record Quarterly Net Revenue, from Both Amazon and E-Commerce Business Segment

New York, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Receives Product Endorsement From the State of Alaska

Endorsement Applies to: Tauri-Gum™ Product Line   New York, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB:...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Set to Report Record Quarterly Net Revenue

Continued Strength in E-Commerce Business Segment has Driven Revenue Growth  New York, NY, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review Board

Protocol Title: The Effect of CBD Gum on Nausea and Vomiting During Pregnancy New York, NY, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Approved to Renew its Status as a Vendor to the National Association of College Stores

NEW YORK, NY, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The Company Will Operate Corporate Exhibitor Booth at NACS Campus Market 2022 Tradeshow  ...

TAUG : 0.0001 (unch)
Tauriga Sciences Inc. Generates Record Weekly Net E-Commerce Sales

For the Following Weekly Period: November 22nd-28th, 2021 or Thanksgiving Week 2021 NEW YORK, NY, Nov. 29, 2021 (GLOBE NEWSWIRE) --...

TAUG : 0.0001 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Tauriga Sciences, Inc. is a diversified life sciences company focused on the development of a proprietary technology platform in the synthetic biology space. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire...

See More

Key Turning Points

3rd Resistance Point 0.0001
2nd Resistance Point 0.0001
1st Resistance Point 0.0001
Last Price 0.0001
1st Support Level 0.0001
2nd Support Level 0.0001
3rd Support Level 0.0001

See More

52-Week High 0.0350
Fibonacci 61.8% 0.0217
Fibonacci 50% 0.0176
Fibonacci 38.2% 0.0134
Last Price 0.0001
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar